Skip to content

Efficacy Evaluation and Predictive Factors Analysis of CT-Guided Percutaneous Intraorbital Triamcinolone Acetonide Injection for Upper Eyelid Retraction in Thyroid Eye Disease

Efficacy Evaluation and Predictive Factors Analysis of CT-Guided Percutaneous Intraorbital Triamcinolone Acetonide Injection for Upper Eyelid Retraction in Thyroid Eye Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119776
Enrollment
Unknown
Registered
2026-03-03
Start date
2026-03-15
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid eye disease upper eyelid retraction

Interventions

Healer Group:None
Non-cured group:None

Sponsors

Eye Hospital of Wenzhou Medical University(Hangzhou Branch)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Diagnosis of TED according to the Bartley criteria. 2.Age >=18 years and = 0 mm), or the margin reflex distance 1 (MRD1) MRD1 of the affected eye differs from that of the contralateral eye by >=1 mm.

Exclusion criteria

Exclusion criteria: 1.Ocular proptosis >23 mm, strabismus or restrictive ocular dysmotility, compressive optic neuropathy, or exposure keratitis. 2.Systemic or local use of glucocorticoids, immunosuppressants, or biological agents within 3 months prior to TA treatment. 3.Local eyelid injection of botulinum toxin within 6 months prior to TA treatment. 4.History of orbital decompression surgery. 5.History of orbital radiotherapy. 6.Contralateral eye complicated by ocular myasthenia gravis. 7.Absence of orbital CT images or poor image quality.

Design outcomes

Primary

MeasureTime frame
Cure rate and total effective rate;

Secondary

MeasureTime frame
complication rate;

Countries

China

Contacts

Public ContactFang Wei

Eye Hospital of Wenzhou Medical University(Hangzhou Branch)

andyfang000@163.com+86 571 86072073

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026